PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1073949
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1073949
Global Analgesics Market is valued at approximately USD 77.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.6 % over the forecast period 2022-2028. Analgesics, commonly known as painkillers, are drugs that alleviate a variety of pains, including headaches, injuries, and arthritis. Different types of Analgesics exhibit different mechanisms of action, anti-inflammatory analgesics diminish inflammation, while opioid analgesics alter pain perception in the brain. Rising advancements in Pain Management measures, expanding manufacturing facilities, and rising prevalence of chronic and neuropathic pain have driven the adoption of Analgesics across the projected period. For Instance: According to the National Health Institute's documentation from 2016, over 20% of adults in the United States suffer from chronic pain, with 8% having high-impact chronic pain. This has boosted the need for analgesics in the country. Also, commercializing opioid tolerant drugs and introduction of non-opioid analgesics in the market are most likely to boost the overall growth of the Analgesics market. However, misuse of opioids and government restrictions on the sale and prescription of opioids can obstruct the market's expansion over the projection period of 2021-2027.
The key regions considered for the global Analgesics market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising prevalence of chronic pain is driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. The market is expected to grow during the projected period, due to rising utilization of Analgesics and introduction of non-opioid analgesics in this region.
Major market players included in this report are:
Pfizer Inc.
Sun Pharmaceuticals Industries Inc.
Sanofi SA
AbbVie Inc.
Teva Pharmaceuticals Inc.
Endo Pharmaceuticals, Inc.
Assertio Therapeutics, Inc.
GlaxoSmithKline Plc.
Bausch Health Companies Inc.
Novartis AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Opioids
NSAIDs
Local Anesthetics
Acetaminophen
By Indication:
Surgical Pain
Cancer Pain
Neuropathic Pain
Others
By Route of Administration:
Oral
Parenteral
Transdermal
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Store
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Analgesics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
12.1 Research Process
12.2 Research Attributes
12.3 Research Assumption
List of figures